Derma Sciences Income Statement
View: Annual
| Dec 08 | Dec 07 | Dec 06 | |
|---|---|---|---|
| Revenue | 50.2 | 34.1 | 27.9 |
| Cost of Goods Sold | 35.3 | 22.5 | 18.2 |
| Gross Profit | 14.9 | 11.6 | 9.7 |
| Gross Profit Margin | 29.7% | 34.0% | 34.6% |
| SG&A Expense | 17.2 | 11.9 | 8.3 |
| Depreciation & Amortization | 2.3 | 1.4 | 1.0 |
| Operating Income | (3.0) | (1.6) | 1.2 |
| Operating Margin | -- | -- | 4.2% |
| Nonoperating Income | (0.0) | (0.1) | 0.0 |
| Nonoperating Expenses | (0.9) | -- | -- |
| Income Before Taxes | (3.9) | (2.0) | 0.8 |
| Income Taxes | 0.1 | 0.3 | 0.1 |
| Net Income After Taxes | (4.0) | (2.3) | 0.7 |
| Continuing Operations | (4.0) | (2.3) | 0.7 |
| Discontinued Operations | -- | -- | -- |
| Total Operations | (4.0) | (2.3) | 0.7 |
| Total Net Income | (4.0) | (2.3) | 0.7 |
| Net Profit Margin | -- | -- | 2.4% |
| Diluted EPS from Total Net Income ($) | (0.10) | (0.09) | 0.03 |
| Dividends per Share | 0.00 | 0.00 | 0.00 |
© 2009 Morningstar, Inc. Financial Data provided by
